SWISS RE LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89 EUR | +0.23% |
|
-.--% | -.--% |
| Jul. 08 | Swiss Re Unit to Fully Redeem $631 Million of Notes | MT |
| Jul. 05 | SWISS REINSURANCE COMPANY : JP Morgan gives a Buy rating | ZD |
| Sales 2024 * | 48.46B 44.52B | Sales 2025 * | 50.46B 46.37B | Capitalization | 35.93B 33.01B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.92B 3.61B | Net income 2025 * | 4.27B 3.93B | EV / Sales 2024 * | 0.86 x |
| Net Debt 2024 * | 5.67B 5.21B | Net Debt 2025 * | 5.62B 5.16B | EV / Sales 2025 * | 0.82 x |
| P/E ratio 2024 * |
9.34
x | P/E ratio 2025 * |
8.52
x | Employees | 14,719 |
| Yield 2024 * |
5.87% | Yield 2025 * |
6.31% | Free-Float | 91.32% |
More Fundamentals
* Assessed data
More news
Latest transcript on Swiss Re Ltd
More recommendations
More press releases
| 1 day | +0.23% |
10 years
57.21
93.85
| Managers | Title | Age | Since |
|---|---|---|---|
Andreas Berger
CEO | Chief Executive Officer | 57 | 19-02-28 |
John Dacey
DFI | Director of Finance/CFO | 64 | 12-09-30 |
Velina Peneva
CIO | Chief Investment Officer | - | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Larry Zimpleman
BRD | Director/Board Member | 72 | 18-04-19 |
| Director/Board Member | 68 | 17-04-20 | |
| Chairman | 63 | 17-04-20 |
Swiss Re Ltd is one of the world's leading reinsurance groups. Earned premiums break down by activity as follows:
- non-life reinsurance (51.6%): primarily damage, civil liability, automobile, accident, credit and guarantee, and other types of reinsurance;
- life and health reinsurance (34.7%; No. 1 worldwide): primarily life (69.2% of earned premiums) and health (30.8%);
- financial services (12.6%): asset management, investment capital, financial consulting, sales of structured products, etc.;
- others (1.1%).
Sector
Reinsurance
Calendar
2024-08-21
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
123.7
USD
Average target price
128.8
USD
Spread / Average Target
+4.09%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +30.89% | 8.67B | |
| +11.22% | 6.53B | |
| -2.27% | 5.03B | |
| +9.60% | 4.73B | |
| +11.19% | 854M | |
| +16.92% | 665M | |
| +24.29% | 586M | |
| +90.98% | 389M | |
| +17.97% | 168M |
- Stock Market
- Equities
- SREN Stock
- SR9 Stock
